These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 15554934)

  • 1. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone.
    Makar SH; Sawires HK; Farid TM; Ali WM; Schaalan M
    Iran J Kidney Dis; 2010 Oct; 4(4):327-32. PubMed ID: 20852376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
    Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
    De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
    Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and pmma) during hemodialysis treatment using SELDI-TOF-MS.
    Ishikawa I; Chikazawa Y; Sato K; Nakagawa M; Imamura H; Hayama S; Yamaya H; Asaka M; Tomosugi N; Yokoyama H; Matsumoto K
    Am J Nephrol; 2006; 26(4):372-80. PubMed ID: 16873993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High- and low-flux acetate-free biofiltration: experimental assessment of calcium mass balance and intact parathyroid hormone behaviour.
    de Vincenzi A; Bellazzi RG; Santagostino M; Gazo A; Romanini D; Nai M; Maretti L; Ornati G; Bellazzi R
    Nephrol Dial Transplant; 1994; 9(9):1305-9. PubMed ID: 7816296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
    van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC; Chen CA; Wang CT; Chen HC
    Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in parathyroid hormone during haemodialysis sessions with two different dialysis membranes: specific adsorption of intact parathyroid hormone.
    Valat C; Pengloan J; Blanchier D; Bagros P; Besnard JC
    Nucl Med Commun; 1993 Feb; 14(2):130-6. PubMed ID: 8429992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.